Non-neurologic Late Effects of Therapy

Abstract

With the overall 5-year survival of patients diagnosed with cancer during childhood and adolescence now exceeding 80%, these survivors represent a rapidly growing population who may be burdened with adverse late toxicities and chronic disease. The chapter is organized by organ systems involved and addresses many of the more common adverse non-neurologic treatment-related late effects. The mechanisms of and risk factors for their development and imaging methods for their detection are discussed.